byrn pharma

Nearly 170 investors pour $28M into Raleigh startup focusing on counter to deadly allergic reactions

Posted by WRAL TechWire | Dec 21, 2021

Investors are flocking to Raleigh startup Byrn Pharma, which offers a needle-free means of administering epinephrine via a nasal spray to combat anaphylaxis. Here’s an update.

Raleigh life science firm Bryn Pharma raises $17.2M

Posted by WRAL TechWire | Feb 25, 2019

A Raleigh-based life science company raised $17.2 million in a private equity offering, according to a securities filing.

byrn pharma

Nearly 170 investors pour $28M into Raleigh startup focusing on counter to deadly allergic reactions

Raleigh life science firm Bryn Pharma raises $17.2M

Categories

Tags